Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Loss of primary cilia promotes inflammation and carcinogenesis.
Paul C, Tang R, Longobardi C, Lattanzio R, Eguether T, Turali H, Bremond J, Maurizy C, Gabola M, Poupeau S, Turtoi A, Denicolai E, Cufaro MC, Svrcek M, Seksik P, Castronovo V, Delvenne P, de Laurenzi V, Da Costa Q, Bertucci F, Lemmers B, Pieragostino D, Mamessier E, Janke C, Pinet V, Hahne M. Paul C, et al. Among authors: denicolai e. EMBO Rep. 2022 Dec 6;23(12):e55687. doi: 10.15252/embr.202255687. Epub 2022 Oct 25. EMBO Rep. 2022. PMID: 36281991 Free PMC article.
Ex vivo cultures of glioblastoma in three-dimensional hydrogel maintain the original tumor growth behavior and are suitable for preclinical drug and radiation sensitivity screening.
Jiguet Jiglaire C, Baeza-Kallee N, Denicolaï E, Barets D, Metellus P, Padovani L, Chinot O, Figarella-Branger D, Fernandez C. Jiguet Jiglaire C, et al. Among authors: denicolai e. Exp Cell Res. 2014 Feb 15;321(2):99-108. doi: 10.1016/j.yexcr.2013.12.010. Epub 2013 Dec 16. Exp Cell Res. 2014. PMID: 24355810
Identification of Atypical Circulating Tumor Cells with Prognostic Value in Metastatic Breast Cancer Patients.
Lopresti A, Acquaviva C, Boudin L, Finetti P, Garnier S, Aulas A, Liberatoscioli ML, Cabaud O, Guille A, de Nonneville A, Da Costa Q, Denicolai E, Pakradouni J, Goncalves A, Birnbaum D, Bertucci F, Mamessier E. Lopresti A, et al. Among authors: denicolai e. Cancers (Basel). 2022 Feb 13;14(4):932. doi: 10.3390/cancers14040932. Cancers (Basel). 2022. PMID: 35205679 Free PMC article.
Molecular Profiles of Advanced Urological Cancers in the PERMED-01 Precision Medicine Clinical Trial.
Billon E, Gravis G, Guille A, Carbuccia N, Adelaide J, Garnier S, Finetti P, Denicolaï E, Sfumato P, Brunelle S, Thomassin-Piana J, Pignot G, Walz J, Chabannon C, Pakradouni J, Sabatier R, Vicier C, Popovici C, Mamessier E, Gonçalves A, Birnbaum D, Chaffanet M, Bertucci F. Billon E, et al. Among authors: denicolai e. Cancers (Basel). 2022 May 3;14(9):2275. doi: 10.3390/cancers14092275. Cancers (Basel). 2022. PMID: 35565404 Free PMC article.
Immunologic constant of rejection as a predictive biomarker of immune checkpoint inhibitors efficacy in non-small cell lung cancer.
Mogenet A, Finetti P, Denicolai E, Greillier L, Boudou-Rouquette P, Goldwasser F, Lumet G, Ceccarelli M, Birnbaum D, Bedognetti D, Mamessier E, Barlesi F, Bertucci F, Tomasini P. Mogenet A, et al. Among authors: denicolai e. J Transl Med. 2023 Sep 19;21(1):637. doi: 10.1186/s12967-023-04463-2. J Transl Med. 2023. PMID: 37726776 Free PMC article.
18 results